Skip to content

Olaparib

Also known as Lynparza (us), Olanib (india)

Cancer & Oncology
Save $4,024/mo
65× cheaper

Olaparib is used alone or in combination with bevacizumab (Avastin) to help maintain the response of certain types of ovarian (female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), and peritoneal (layer of tissue that lin…

United States
$4,088
per month
India
$63
per month
You save
$4,024
98% cheaper in India
41.4K US scripts/yr$166.8M potential annual savings$169.4M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC24H23FN4O3

SMILES: C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F

Compare the price
US price$4,088per month
India price$63per month
You save$4,02498% less

Based on 30 units per month. US $136.25 vs India $2.11 per unit.

Total over 1 periodSave $4,024$4,088$63
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$24,146
Estimated travel cost
− $2,300
Net savings after travel
$21,846

Even after travel, you could come out ahead by about $21,846.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Olaparib is filled about 41.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$169.4M
If sourced from India
$2.6M
Potential annual savings
$166.8M
98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.